LRRC33 is a novel binding and potential regulating protein of TGF-β1 function in human acute myeloid leukemia cells

• Wenjiang Ma ,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: Wenjiang_Ma@dfci.harvard.edu

  Affiliations Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America, Harvard Medical School, Boston, MA, United States of America

  http://orcid.org/0000-0003-0261-8499

  ⨯
• Yan Qin,

  Roles Conceptualization, Validation, Writing – review & editing

  Affiliations Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America, Harvard Medical School, Boston, MA, United States of America

  ⨯
• Bjoern Chapuy,

  Roles Software, Writing – review & editing

  Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America

  ⨯
• Chafen Lu

  Roles Methodology, Validation, Writing – review & editing

  Affiliations Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA, United States of America, Harvard Medical School, Boston, MA, United States of America

  ⨯